These findings suggest that SQ-TMZ NPs enhance the sensitivity of resistant T98G cells to TMZ by effectively suppressing MGMT expression, providing further evidence of their potential as a promising therapeutic strategy for overcoming TMZ resistance in glioma cells (Figure 6E–G). This evidence concerns the gene MGMT and glioma.